Sign in

CIK 0001438533 · Large accelerated filer

Travere Therapeutics, Inc.

Sign in to watch
Ticker
TVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
operating
EIN
262383102
Phone
888-969-7879
Business address
3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
Former names
Retrophin, Inc., Desert Gateway, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$80,128,453
in 11 filings, $80.1M under 10b5-1 plans

Net −$80,128,453. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Dube Eric M −$38.5M CHIEF EXECUTIVE OFFICER sold 60% of stake
  2. Heerma Peter −$17.9M EVP, CHIEF COMMERCIAL OFFICER sold 71% of stake
  3. ROTE WILLIAM E. −$13.1M Chief Research Officer sold 68% of stake
  4. Cline Christopher R. −$3.2M CHIEF FINANCIAL OFFICER sold 37% of stake
  5. Inrig Jula −$2.8M EVP, Head of R&D & CMO sold 31% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-05-14 Bruhn Suzanne Louise Director Grant or award · Stock option (right to buy) +9,000 9,000
2021-05-14 Baynes Roy D. Director Grant or award +3,000 17,000
2021-05-14 Baynes Roy D. Director Grant or award · Stock option (right to buy) +9,000 9,000
2021-05-14 LYONS GARY A Director Grant or award +3,000 37,000
2021-05-14 LYONS GARY A Director Grant or award · Stock option (right to buy) +9,000 9,000
2021-05-14 ASELAGE STEVE Director Grant or award +3,000 189,794
2021-05-14 ASELAGE STEVE Director Grant or award · Stock option (right to buy) +9,000 9,000
2021-05-14 Meckler Jeffrey A Director Grant or award +3,000 67,000
2021-05-14 Meckler Jeffrey A Director Grant or award · Stock option (right to buy) +9,000 9,000
2021-05-14 Orwin John A Director Grant or award +3,000 14,875
2021-05-14 Orwin John A Director Grant or award · Stock option (right to buy) +9,000 9,000
2021-05-14 Poole Sandra Director Grant or award +3,000 9,500
2021-05-14 Poole Sandra Director Grant or award · Stock option (right to buy) +9,000 9,000
2021-05-14 Squarer Ron Director Grant or award +3,000 14,875
2021-05-14 Squarer Ron Director Grant or award · Stock option (right to buy) +9,000 9,000
2021-05-12 ROTE WILLIAM E. Senior Vice President, R&D Sale −1,562 $19.46 $30K 31,707
2021-05-12 Rosenberg Noah L. Chief Medical Officer Sale −375 $19.46 $7K 45,594
2021-05-12 REED ELIZABETH E SVP, GC & Corporate Secretary Sale −1,625 $19.46 $32K 34,455
2021-05-12 Clague Laura Chief Financial Officer Sale −2,000 $19.46 $39K 28,223
2021-05-11 ROTE WILLIAM E. Senior Vice President, R&D Sale −1,563 $19.14 $30K 33,269

Page 35 of 51 · 1,020 trades